Waiting Times for Surgery and Radiotherapy Among Breast Cancer Patients in Switzerland: A Cancer Registry-Based Cross-Sectional and Longitudinal Analysis
Open Access
Abstract
Background: Delays in breast cancer treatment negatively affect prognosis and have increased over time. Data on waiting times in Switzerland are limited. Patients and Methods: This study analyzed cancer registry data from 2003 to 2005 (2628 patients) and 2015 to 2017 (421 patients) to evaluate waiting times for diagnosis, surgery, and radiotherapy; temporal trends; and survival in women with stage I–III invasive breast cancer treated with surgery without chemotherapy. Associations with demographic/clinical factors and overall survival (OS) were assessed using ANOVA, uni-/multivariable regression, Kaplan–Meier, and Cox regression. Results: From 2003 to 2005, mean intervals were biopsy-to-diagnosis 4.3 days, diagnosis-to-surgery 18.8 days, biopsy-to-surgery 26.8 days, and surgery-to-radiotherapy 56.7 days. Longer diagnosis-to-surgery times were associated with metropolitan areas, public hospitals, basic insurance, mastectomy, and older age (all p < 0.001). Radiotherapy delays were also longer in metropolitan areas and after mastectomy (p < 0.001). Between 2003–2005 and 2015–2017, diagnosis-to-surgery times rose in Eastern Switzerland (from 21.3 to 31.2 days), while radiotherapy timing remained stable. Five-year overall survival improved (from 76.7% to 88.4%), but was not significantly impacted by diagnosis-to-surgery intervals. Conclusions: Despite timely surgery in Switzerland (2003–2005), disparities existed, and time to surgery increased by 2015–2017. Reducing waiting times remains important despite no significant short-term OS impact.Keywords
Funding Information
- Swiss Cancer League (Krebsliga Schweiz) (HSR-4663-11-2018)
This publication has 45 references indexed in Scilit:
- Reexamining Time From Breast Cancer Diagnosis to Primary Breast SurgeryJAMA Surgery, 2023
- Delay in the diagnosis and treatment of breast cancer in VietnamCancer Medicine, 2021
- Impact of delayed treatment in women diagnosed with breast cancer: A population‐based studyCancer Medicine, 2020
- Time-to-surgery and overall survival after breast cancer diagnosis in a universal health systemBreast Cancer Research and Treatment, 2019
- Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: A population‐based cohort studyInternational Journal of Cancer, 2018
- Clinical auditing as an instrument for quality improvement in breast cancer care in the Netherlands: The national NABON Breast Cancer AuditJournal of Surgical Oncology, 2016
- Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast CancerJAMA Oncology, 2016
- Time to Surgery and Breast Cancer Survival in the United StatesJAMA Oncology, 2016
- Delay in Surgical Treatment and Survival After Breast Cancer Diagnosis in Young Women by Race/EthnicityJAMA Surgery, 2013
- A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancerBreast Cancer Research and Treatment, 2004